PT-141
In stock
CAS 189691-06-3 · 2 mg/strip · 30 strips/box
PT-141 (bremelanotide) is a single-molecule research peptide intended for laboratory research use only. This product is designed for in-vitro research, analytical testing, formulation study, and non-clinical evaluation related to melanocortin-receptor signaling, peptide stability, and compound characterization.
$79.99
Pack size
Every batch is verified by an independent accredited lab. Current lot: PS-2605-089 · 98.9% purity (HPLC).
View COAFor laboratory research use only. Not for human or veterinary use, or for use in diagnostic or therapeutic procedures.
Overview
What researchers study PT-141 for.
PT-141 (bremelanotide) has been studied in receptor-binding and central-signaling models, with research exploring its activity as a cyclic melanocortin-receptor agonist, its selectivity across the melanocortin receptor subtypes (notably MC4R), and its downstream cAMP and central-nervous-system signaling responses. These findings characterize PT-141 as an α-MSH-derived agonist acting through the central melanocortin system in preclinical settings.
Handling
Reconstitution-free, room-temperature stable.
- 1
Store cold & dry
Keep strips sealed in the foil sleeve at room temperature, away from moisture.
- 2
Handle with dry hands
Remove one film only when ready to use; the strip dissolves within 30–60 seconds on contact with liquid.
- 3
Log the batch
Record the lot number for your research documentation and pair it with the matching COA.
Quality & Testing
Certificate of Analysis for this batch.
Independently verified by an ISO/IEC 17025-accredited laboratory before release.
Current lot
PS-2605-089
Tested May 20, 2026 · 98.9% purity (HPLC)
See all batch COAsPT-141 · Dissolving strip
| Test | Specification | Result | Status |
|---|---|---|---|
| Purity (HPLC-UV) | ≥ 98.0% | 98.9% | PASS |
| Endotoxin (LAL) | ≤ 0.5 EU/mg | < 0.1 EU/mg | PASS |
Results relate only to the batch tested. Issued for research quality-assurance purposes; not approval for human or veterinary use.




